ORAL-CONTRACEPTIVES AND VASCULAR-DISEASE

被引：47
作者：
SARTWELL, PE
STOLLEY, PD
机构：
[1] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21218
[2] UNIV PENN,SCH MED,GEN MED SECT,CLIN EPIDEMIOL UNIT,PHILADELPHIA,PA 19104
来源：
EPIDEMIOLOGIC REVIEWS | 1982年 / 4卷
关键词：
D O I：
10.1093/oxfordjournals.epirev.a036253
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：95 / 109
页数：15
相关论文
共 74 条
  • [1] ANDERSON TW, 1970, CAN MED ASSOC J, V102, P1156
  • [2] [Anonymous], 1973, Lancet, V1, P1399
  • [3] [Anonymous], 1973, JAMA
  • [4] CARDIOVASCULAR-DISEASE AND ORAL-CONTRACEPTIVES - REAPPRAISAL OF VITAL STATISTICS DATA
    BELSEY, MA
    RUSSELL, Y
    KINNEAR, K
    [J]. FAMILY PLANNING PERSPECTIVES, 1979, 11 (02): : 84 - 89
  • [5] BERAL V, 1976, LANCET, V2, P1047
  • [6] BLACKARD CE, 1970, CANCER, V26, P249, DOI 10.1002/1097-0142(197008)26:2<249::AID-CNCR2820260202>3.0.CO
  • [7] 2-7
  • [8] BOTTIGER LE, 1980, LANCET, V1, P1097
  • [9] SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN USING ORAL-CONTRACEPTIVES, ESTROGENS AND PROGESTINS
    BRADLEY, DD
    WINGERD, J
    PETITTI, DB
    KRAUSS, RM
    RAMCHARAN, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (01) : 17 - 20
  • [10] CHUMNIJARAKIJ T, 1975, LANCET, V1, P1357
12345678